Windtree Therapeutics, Inc.
WINT
$0.05
$0.00-5.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.86M | 1.80M | 1.82M | 1.73M | 2.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.75M | 3.98M | 4.09M | 3.92M | 4.74M |
| Operating Income | -3.75M | -3.98M | -4.09M | -3.92M | -4.74M |
| Income Before Tax | -31.52M | -10.63M | -4.05M | 2.69M | -2.99M |
| Income Tax Expenses | -3.43M | -- | -- | -77.00K | -240.00K |
| Earnings from Continuing Operations | -28.09M | -10.63M | -4.05M | 2.77M | -2.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.09M | -10.63M | -4.05M | 2.77M | -2.75M |
| EBIT | -3.75M | -3.98M | -4.09M | -3.92M | -4.74M |
| EBITDA | -3.39M | -3.97M | -4.07M | -3.90M | -4.72M |
| EPS Basic | -1.08 | -3.06 | -4.63 | 0.40 | -211.39 |
| Normalized Basic EPS | -0.36 | -1.37 | -2.31 | 16.24 | -107.81 |
| EPS Diluted | -1.08 | -3.06 | -4.63 | 0.40 | -211.39 |
| Normalized Diluted EPS | -0.36 | -1.37 | -2.31 | 16.24 | -107.81 |
| Average Basic Shares Outstanding | 26.68M | 4.88M | 1.09M | 171.80K | 17.70K |
| Average Diluted Shares Outstanding | 26.68M | 4.88M | 1.09M | 171.80K | 17.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | 0.00% | -2.22% | 11.20% | -12.62% |